£20.00

Addressing Unmet Medical Needs in Relapsing-Remitting Multiple Sclerosis

Price data last checked 25 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£20 today · previous high £20 · all-time low £20

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 66 days · 66 data points (no recent data)

Historical
Generating forecast…
£20.00 £19.78 £19.83 £19.88 £19.92 £19.97 £20.02 11 June 2026 27 June 2026 13 July 2026 29 July 2026 15 August 2026

Price Distribution

Price distribution over 66 days • 1 price levels

Days at Price
66 days 0 17 33 50 66 £20 Days at Price

Price Analysis

Most common price: £20 (66 days, 100.0%)

Price range: £20 - £20

Price levels: 1 different prices over 66 days

Description

More than two decades since the first disease-modifying therapies became available to treat MS, the field of MS therapeutics is evolving faster than ever. The first injectable disease-modifying therapies brought hope and help to those fighting a previously untreatable disease. One chapter of the book is devoted to emerging oral therapies as a therapeutic modality - an approach that is more accessible and can improve compliance relative to the injectable approaches that are still used worldwide as first-line treatment. As more treatments for RRMS emerge, there will be a greater need to base treatment decisions on disease or biological characteristics in individual patients. Monoclonal antibodies and antigen-receptor therapies are examples of how the potential exists to suppress MS disease activity through a variety of different mechanisms of action. In addition, one of the most important new frontiers is development of strategies for neuroprotection and neurorepair. Novel biological pathways and therapeutics are also being explored for their ability to enhance innate repair mechanisms and remyelination. This book provides an overview of these current and emerging approaches and highlights those areas of current research on novel interventions that hold major promise for the future.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
11 January 2011
Listed Since
06 January 2012

Barcode

No barcode data available

Similar Products You Might Like

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments
85% match

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Springer

£80.67 05 Aug 2026
Multiple Sclerosis: Practical Comprehensive Essentials
83% match

Multiple Sclerosis: Practical Comprehensive Essentials

£75.00 14 Aug 2026
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)
83% match

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Springer

£76.42 05 Aug 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
82% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£144.64 08 Aug 2026
Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis (Topics in Neuroscience)
82% match

Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis (Topics in Neuroscience)

Springer

£64.80 30 Jul 2026
Molecular Biology of Multiple Sclerosis
81% match

Molecular Biology of Multiple Sclerosis

Wiley-Blackwell

Price unavailable
Multiple Sclerosis: Diagnosis and Therapy
81% match

Multiple Sclerosis: Diagnosis and Therapy

Wiley-Blackwell

£71.99 01 Aug 2026
Emerging Oral Medications for Multiple Sclerosis
80% match

Emerging Oral Medications for Multiple Sclerosis

£60.00 10 Aug 2026
80% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 04 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
80% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 18 Aug 2026
Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)
80% match

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Springer

£109.24 10 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
79% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026
Personalized Management of Multiple Sclerosis
79% match

Personalized Management of Multiple Sclerosis

£120.00 10 Aug 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science
78% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Springer

£108.01 07 Aug 2026
Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)
78% match

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Springer

£108.01 04 Aug 2026
Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases: Case-Based Learning
78% match

Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases: Case-Based Learning

Cambridge University Press

£57.99 30 Jul 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
78% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 08 Aug 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
77% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.01 12 Aug 2026
77% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Academic Press

£157.99 04 Aug 2026
Multiple Sclerosis: The Progressive Demyelinating Autoimmune Disease
77% match

Multiple Sclerosis: The Progressive Demyelinating Autoimmune Disease

Tellwell Talent

£45.00 31 Jul 2026
Messenger RNA Therapeutics: 13 (RNA Technologies, 13)
77% match

Messenger RNA Therapeutics: 13 (RNA Technologies, 13)

Springer

£107.98 19 Aug 2026
Immune For Life: forgotten factors for life and health that are shaping the future of drugs and food
77% match

Immune For Life: forgotten factors for life and health that are shaping the future of drugs and food

Independently Published

Price unavailable
MRI Atlas of MS Lesions
76% match

MRI Atlas of MS Lesions

Springer

£80.64 10 Aug 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
76% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 05 Aug 2026